Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-12 08:41 am Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | MACQUARIE GROUP LTD | 2,763,922 5.41% | 2,763,922 (New Position) | View |
| 2021-02-11 4:31 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | INTEGRATED CORE STRATEGIES (US) LLC | 727,176 1.4% | 727,176 (New Position) | View |
| 2021-02-10 11:57 am Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | VANGUARD GROUP INC | 3,404,443 6.67% | 3,404,443 (New Position) | View |
| 2021-02-03 8:55 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | MANULIFE FINANCIAL CORP MFC | 2,157,055 11% | 2,157,055 (New Position) | View |
| 2021-02-01 08:17 am Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | BlackRock Inc. BLK | 4,825,174 9.5% | 4,825,174 (New Position) | View |
| 2021-01-04 4:05 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,850,000 5.58% | 2,850,000 (New Position) | View |
| 2020-02-14 4:34 pm Purchase | 13G | RETROPHIN, INC. RTRX | RA CAPITAL MANAGEMENT L.P. | 4,252,453 9.9% | 4,252,453 (New Position) | View |
| 2020-02-14 4:17 pm Sale | 13G | RETROPHIN, INC. RTRX | PERCEPTIVE ADVISORS LLC | 2,890,608 6.7% | -508,930 (-14.97%) | View |
| 2020-02-14 3:49 pm Sale | 13G | RETROPHIN, INC. RTRX | Consonance Capital Management LP | 2,314,421 5.39% | -1,717,702 (-42.60%) | View |
| 2020-02-14 3:34 pm Sale | 13G | RETROPHIN, INC. RTRX | SCOPIA CAPITAL MANAGEMENT LP | 2,011,697 4.7% | -1,279,615 (-38.88%) | View |
| 2020-02-13 5:13 pm Sale | 13G | RETROPHIN, INC. RTRX | Broadfin Capital LLC | 0 0% | -2,077,432 (Position Closed) | View |
| 2020-02-13 11:36 am Purchase | 13G | RETROPHIN, INC. RTRX | MACQUARIE GROUP LTD | 3,077,128 7.16% | 811,204 (+35.80%) | View |
| 2020-02-12 2:26 pm Purchase | 13G | RETROPHIN, INC. RTRX | MANULIFE FINANCIAL CORP MFC | 2,317,269 11% | 2,317,269 (New Position) | View |
| 2020-02-11 4:40 pm Purchase | 13G | RETROPHIN, INC. RTRX | VANGUARD GROUP INC | 2,523,335 5.87% | 2,523,335 (New Position) | View |
| 2020-01-28 4:46 pm Purchase | 13G | RETROPHIN, INC. RTRX | INTEGRATED CORE STRATEGIES (US) LLC | 2,223,250 5.2% | 2,223,250 (New Position) | View |
| 2020-01-10 2:51 pm Purchase | 13G | RETROPHIN, INC. RTRX | BlackRock Inc. BLK | 4,341,899 10.1% | 711,766 (+19.61%) | View |
| 2019-08-12 4:02 pm Sale | 13G | RETROPHIN, INC. RTRX | SCOPIA CAPITAL MANAGEMENT LP | 3,291,312 7.9% | -2,619,541 (-44.32%) | View |
| 2019-07-19 4:20 pm Purchase | 13G | RETROPHIN, INC. RTRX | Broadfin Capital LLC | 2,077,432 5.01% | 161,441 (+8.43%) | View |